Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine. The FDA has official signed off on the trial, according to a statement from Novartis, and…

Treating the new coronavirus with hydroxychloroquine is associated with an increase in overall mortality, according to new research involving U.S. veterans. The combination of hydroxychloroquine and azithromycin also led to an…

Coala Life, a healthcare technology company based out of Sweden, has announced that physicians will now be able to use the company’s Coala Heart Monitor to conduct virtual heart and lung examinations.

Researchers examining chloroquine (CQ), an antimalarial medication often suggested as a potential treatment for COVID-19, ended their study early over fears that patients were at an increased risk of significant heart…

Warfarin use does not reduce the risk of stroke for end-stage renal disease (ESRD) patients with AFib, according to a new meta-analysis published…

A French hospital testing the effectiveness of hydroxychloroquine on COVID-19 patients had to immediately stop testing on one patient due to the risk of significant cardiac side effects.

…

Smartphone cameras could play an important role in the diagnosis of AFib, according to new findings published in JAMA Network Open.…

Oral anticoagulation medication can help minimize bleeding complications among AFib patients undergoing transcatheter aortic valve replacement (TAVR), according to new research out of Europe. When those patients are also…

A significant number of life-threatening complications in pregnant women with heart disease could be prevented altogether, according to new findings published by the…

A patient’s e-cigarette interfered with their implantable cardioverter-defibrillator (ICD) and prevented the device from properly functioning, according to a…

On a biweekly basis, researchers and physicians at the Feinstein Institutes for Medical Research and North Shore University Hospital in New York gather to watch footage of patient resuscitations.…

Nearly a quarter of older patients with atrial fibrillation receive inappropriately dosed direct-acting oral anticoagulants (DOACs), according to an analysis of the ongoing SAGE-AF (Systematic Assessment of…

A new analysis of the CASTLE-AF (Catheter Ablation for Atrial Fibrillation with Heart Failure) trial has found that catheter ablation for AFib remains effective in a much larger group of heart failure patients…

A small-scale study published in Circulation…

Researchers at Imperial College London have developed a new type of sensor that can track vital signs in both humans and animals, suggesting the ever-growing wearables trend is expanding to include pets and…

Pulsed field ablation (PFA) technology has been used to treat atrial fibrillation for the first time in the U.S.

…

A study published Feb. 25 in Circulation…

Medtronic and the FDA were both aware of battery and wire connection defects in a now-recalled heart failure pacemaker for over a year before patients developed serious side effects, according to a report…

A recent analysis of FitBit data suggests there is no one “normal” resting heart rate for humans, with users’ average HR coming in at between 40 and 109 beats per minute, Discover Magazine reported.…

Medtronic has received CE mark approval in the European Union for its Cobalt and Crome implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds).…

A panel of experts from the Clinical Genome Resource (ClinGen) are publicly disputing nine of 17 genes once thought to be linked to long QT syndrome.

…